| abstract |
This invention pertains to aryl pyrrolidinyl and piperidinyl ketone compounds of formula (I) wherein R 1 and R 2 are as described herein, as well as pharmaceutically acceptable salts and esters thereof, and methods for using the same. In particular, compounds of the present invention are useful for treatment of diseases associated with monoamine reuptake inhibition. |